Progress in Mind
Your Psychiatry and Neurology online resource center
Choose a channel
Check out the different Progress in Mind content channels.
Schizophrenia
Article
Strategies for reducing the duration of untreated psychosis
Longer duration of untreated psychosis (DUP) is related to poor clinical and functional outcomes in...
Article
Counting the indirect costs of psychosis
Early intervention (EI) services for people with psychosis are designed to improve outcomes,...
Depression
Article
What do patients want and expect from their treatment for depression?
How aligned are treatment expectations between clinicians and patients? Even in the era of...
Schizophrenia
Article
The effects of antipsychotic dose reduction/discontinuation on long-term outcome in FEP patients
Patients with FEP often ask whether they can discontinue their medication after a period of...
Depression
Article
Innovation and tailored treatments drive improved outcomes in depression
We are a step closer to the early detection of antidepressant treatment failure, a paradigm shift...
Schizophrenia
Article
Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden
One-third of individuals with schizophrenia develop treatment-resistant schizophrenia (TRS); and 70...
Parkinson's Disease
Article
Biomarkers – ever closer in PD
For some time now, researchers have been seeking effective biomarkers for the diagnosis and...
Schizophrenia
Article
Changing the course of schizophrenia: biology, psychology and livelihood
How to manage and mitigate some long-term problems associated with schizophrenia, and improve...
Depression, Schizophrenia
Article
The evolving science of psychiatry
Science is beginning to reinforce the practice of psychiatry through increasing understanding of...
Parkinson's Disease
Article
Biometrics – when, how and why
MDS has for the first time chosen as its main conference theme a topic outside its main remit of...
Schizophrenia
Article
Complementary approaches for improving outcomes in first-episode psychosis
Early intervention (EI) services are designed to improve outcomes in patients with first episode...
Schizophrenia
Article
Early use of a long acting injectable antipsychotic shortens hospital stay for acute schizophrenia
Average hospital stay for patients treated with a long-acting injectable (LAI) antipsychotic...
Featured articles
THINC®
Depression
Seminar
THINC® Online Course
Depression - 29.03.2016
Download
Download the THINC-it® Tool
Depression
Download
THINC-it® physician guide
The THINC-it® user guide is now available and can be downloaded here.
Depression
Interview
THINC-it® tool has now been validated! Its importance for measurement-based care in depression
Depression
Article
THINC-it® cognition screening tool now clinically validated
Depression
Article
Infographic for the health care provider describing THINC-it® as a simple, quick and effective way to screen for cognitive dysfunction in depression
Depression
Article
THINC-it® participant leaflet now available
Recommended videos
Video
Two sides of the same coin
7m:19s
Interview
Professor James MacCabe defines Treatment Resistance Schizophrenia
3m:27s
Video
Professor Mark Opler - Teaming up with patients
9m:09s
Video
Improvement in schizophrenia: Long and short term perspectives
5m:39s
Interview
John FP Bridges – Priorities of people living with SCZ
3m:39s
Video
Better understanding of depression, its symptoms and treatment, is needed
3m:39s
Interview
Control of side effects may be the key to solving the dopamine paradox of schizophrenia
3m:44s
Video
Expert insight: on residual and cognitive symptoms in MDD
Interview
John FP Bridges - Aiming for recovery: the world before Schizophrenia
4m:21s
Most popular on Progress in Mind
Depression, Schizophrenia
Article
ICD-11 – fielding for diagnostic success
In 2018, the World Health Organization (WHO) will release two important documents, both of which should aid for the better diagnosis of mental illness; the newer
Depression
Congress highlights
When to change first-line treatment: Debating an everyday dilemma
Schizophrenia
Congress highlights
Mapping of early intervention programs for psychosis in France
Schizophrenia
Congress highlights
Dopamine D2 partial agonists – efficacy, tolerability and improved functioning?
Parkinson's Disease
Congress highlights
Getting rid of alpha-synuclein – active and passive immunotherapy, or maybe targeting LRRK2?
Alzheimer's Disease
Article
Advances in the early diagnosis of Alzheimer’s Disease
Article